Follow
Fatima Cardoso
Fatima Cardoso
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal
Verified email at fundacaochampalimaud.pt
Title
Cited by
Cited by
Year
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
33552013
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ...
Journal of the National Cancer Institute 98 (4), 262-272, 2006
20882006
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
18312015
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ...
Annals of oncology 26, v8-v30, 2015
16312015
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ...
Journal of the National Cancer Institute 98 (17), 1183-1192, 2006
14142006
70-gene signature as an aid to treatment decisions in early-stage breast cancer
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
13832016
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
E De Azambuja, F Cardoso, G de Castro, M Colozza, MS Mano, ...
British journal of cancer 96 (10), 1504-1513, 2007
10882007
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
J Cortes, J O'Shaughnessy, D Loesch, JL Blum, LT Vahdat, K Petrakova, ...
The Lancet 377 (9769), 914-923, 2011
10652011
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ...
Clinical cancer research 13 (11), 3207-3214, 2007
10452007
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ...
Annals of Oncology 30 (8), 1194-1220, 2019
10222019
4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)
F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ...
Annals of Oncology 29 (8), 1634-1657, 2018
9122018
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
9012017
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F Andre, CH Barrios, ...
The Breast 23 (5), 489-502, 2014
7502014
3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
The Breast 31, 244-259, 2017
7462017
Pembrolizumab for early triple-negative breast cancer
P Schmid, J Cortes, L Pusztai, H McArthur, S Kümmel, J Bergh, C Denkert, ...
New England Journal of Medicine 382 (9), 810-821, 2020
7412020
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Senkus, S Kyriakides, F Penault-Llorca, P Poortmans, A Thompson, ...
Annals of oncology 24, vi7-vi23, 2013
6672013
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F Cardoso, N Harbeck, L Fallowfield, S Kyriakides, E Senkus
Annals of oncology 23, vii11-vii19, 2012
5742012
Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer
S Chan, ME Scheulen, S Johnston, K Mross, F Cardoso, C Dittrich, ...
Journal of Clinical Oncology 23 (23), 5314-5322, 2005
5522005
Clinical application of the 70-gene profile: the MINDACT trial
F Cardoso, L Van't Veer, E Rutgers, S Loi, S Mook, MJ Piccart-Gebhart
Journal of clinical oncology 26 (5), 729-735, 2008
5452008
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2–positive, node-negative tumors 1 cm or smaller
AM Gonzalez-Angulo, JK Litton, KR Broglio, F Meric-Bernstam, R Rakkhit, ...
Journal of clinical oncology 27 (34), 5700, 2009
4892009
The system can't perform the operation now. Try again later.
Articles 1–20